Charles S. Tannenbaum
- Immunology top 1%
- Immunotherapy and Immune Responses 20
- Immune Cell Function and Interaction 11
- Immune cells in cancer 11
- Immune Response and Inflammation 7
- Oncology top 2%
- Chemokine receptors and signaling 10
- Cancer Immunotherapy and Biomarkers 8
- Immunology and Allergy top 5%
- Cancer Research top 10%
- Molecular Medicine top 5%
-
- Cell death mechanisms and regulation 9
- Glycosylation and Glycoproteins Research 8
- Co-authors
- Thomas A. HamiltonJames H. FinkeRonald M. BukowskiPatricia RaymanDavid A. ArmstrongRaymond TubbsTanya DasDolph O. Adams
- Journals
- Journal of Biological Chemistry (2 papers)Journal of Clinical Oncology (3 papers)The Journal of Immunology (16 papers)
- Partner nations
- United StatesIndiaJapan
In The Last Decade
Charles S. Tannenbaum
59 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 105
- Immunology 1.8k
- Oncology 1.2k
- Immunology and Allergy 164
- Cancer Research 295
- Molecular Medicine 81
Countries citing papers authored by Charles S. Tannenbaum
This map shows the geographic impact of Charles S. Tannenbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles S. Tannenbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles S. Tannenbaum more than expected).
Fields of papers citing papers by Charles S. Tannenbaum
This network shows the impact of papers produced by Charles S. Tannenbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles S. Tannenbaum. The network helps show where Charles S. Tannenbaum may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Charles S. Tannenbaum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 9 | |
| 2 | 2021 | 4 | |
| 3 | 2019 | 39 | |
| 4 | 2018 | 74 | |
| 5 | 2018 | 18 | |
| 6 | 2015 | 21 | |
| 7 | 2009 | 55 | |
| 8 | 2009 | 40 | |
| 9 | 2008 | 30 | |
| 10 | 2007 | 93 | |
| 11 | 2004 | 35 | |
| 12 | 2003 | 14 | |
| 13 | Immunotherapy with interleukin-10 depends on the CXC chemokines inducible protein-10 and monokine induced by IFN-gamma. | 2002 | 42 |
| 14 | 2000 | 46 | |
| 15 | 2000 | 67 | |
| 16 | 1998 | 245 | |
| 17 | 1996 | 142 | |
| 18 | 1990 | 1 | |
| 19 | 1988 | 83 | |
| 20 | 1987 | 26 |
About Charles S. Tannenbaum
Charles S. Tannenbaum is a scholar working on Immunology, Oncology and Biotechnology, having authored 59 papers that have together received 2.9k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (20 papers), Immune Cell Function and Interaction (11 papers), Immune cells in cancer (11 papers), Chemokine receptors and signaling (10 papers), Cell death mechanisms and regulation (9 papers), Glycosylation and Glycoproteins Research (8 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Immune Response and Inflammation (7 papers). The work is most often cited by research in Immunology (1.8k citations), Oncology (1.2k citations) and Immunology and Allergy (164 citations). Charles S. Tannenbaum has collaborated with scholars based in United States, India and Japan. Frequent co-authors include Thomas A. Hamilton, James H. Finke, Ronald M. Bukowski, Patricia Rayman, David A. Armstrong, Raymond Tubbs, Tanya Das, Dolph O. Adams, Kaushik Biswas and Andrew C. Novick. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.